Table 1 Formulation of treatments applied in this study.
Treatments | Code | Cd (µM) | MA (µM) | TA (µM) | Replica |
|---|---|---|---|---|---|
T1 | Control | 0 | 0 | 0 | 3 |
T2 | MA1 | 0 | 100 | 0 | 3 |
T3 | MA2 | 0 | 150 | 0 | 3 |
T4 | TA1 | 0 | 0 | 100 | 3 |
T5 | TA2 | 0 | 0 | 150 | 3 |
T6 | Cd | 100 | 0 | 0 | 3 |
T7 | Cd + MA1 | 100 | 100 | 0 | 3 |
T8 | Cd + MA2 | 100 | 150 | 0 | 3 |
T9 | Cd + TA1 | 100 | 0 | 100 | 3 |
T10 | Cd + TA2 | 100 | 0 | 150 | 3 |